Detection and characterization of hepatocellular carcinoma by imaging.

In cirrhotic livers, several types of hepatocellular nodules are found during the diagnosis of hepatocellular carcinoma (HCC). To characterize the nodules is imperative for the optimal management of cirrhotic patients. However, the definitive distinction between early stage, well-differentiated HCC and borderline lesions is still difficult because histologic differences among these nodules are sequential. Therefore, it is important to appreciate the changes on imaging with the progression from benign precancerous nodule to overt HCC and to predict the prognosis of the nodules on the basis of these imaging findings.

[1]  Yasuyuki Arakawa,et al.  Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan , 1999, Annals of Internal Medicine.

[2]  M. Moriyama,et al.  Analysis of Background Factors and Evaluation of a Population at High Risk of Hepatocellular Carcinoma , 2003, Intervirology.

[3]  I. Wanless,et al.  Terminology of nodular hepatocellular lesions , 1995 .

[4]  O. Matsui,et al.  Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. , 2002, Radiology.

[5]  O. Matsui,et al.  Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. , 1999, AJR. American journal of roentgenology.

[6]  M. Makuuchi,et al.  Report of the 15th follow-up survey of primary liver cancer. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[7]  Y. Nakanuma,et al.  Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver disease. , 1998, Histology and histopathology.

[8]  K. Chayama,et al.  Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. , 1998, Journal of hepatology.

[9]  J. Brown Interferon therapy reduces the risk for hepatocellular carcinoma , 2000, Gut.

[10]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[11]  O. Matsui,et al.  Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. , 1991, Radiology.

[12]  T. Terada,et al.  Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study. , 1992, Human pathology.

[13]  E. Tanaka,et al.  Epidemiology and clinical aspects on hepatitis C. , 2002, Japanese journal of infectious diseases.